tirzepatide surpass cvot 🫀 EASD 2025: (SURPASS-CVOT) Dulaglutide head-to-head showdown: ✓ Noninferior for MACE ✓ 16% ↓ all-cause mortality ✓ Superior in A1C & weight loss Tirzepatide confirms its broad cardiometabolic edge. #EASD2025 # Tirzepatide #GLP1 ACC 26: SURPASS-CVOT - Tirzepatide

To view or add a comment, sign in Therapeutic Window and Why Food Drug Interactions Matter

Her openness makes it easier for others to ask questions, explore options, and approach their healthcare providers without feeling embarrassed or judged

Diese Funktion ist unerlsslich fr die Aufrechterhaltung eines gesunden Sauerstoffgehalts im Blut und fr die Untersttzung der Zellatmung

Keeping glucose tablets accessible provides quick correction if needed

This functionalization enables cartilage-targeted delivery, allowing for selective enrichment of GLP-1RAs at diseased joint sites and facilitating precise therapeutic intervention

GHK-Cu is the most well-characterized of the three in terms of extracellular matrix effects